Janssen May Challenge English Funding Rejection For Depression Nasal Spray

 
• By Neena Brizmohun

Health technology assessment body NICE has now rejected Spravato for the third time, saying it has concerns over the clinical evidence and economic model for the drug, for treating adults with major depression that is resistant to treatment.

Male doctor/nurse wearing blue scrubs, with a stethoscope around his neck and holding a Union Jack money purse.
NICE says Spravato would not be an acceptable use of NHS resources • Source: Alamy

More from Market Access

More from Pink Sheet